Ashok K Prasad Selected Research

Ashok K Prasad Research Topics

Disease

6	Neoplasms (Cancer) 12/2022 - 03/2003
4	Inflammation (Inflammations) 01/2013 - 03/2004
2	Glioma (Gliomas) 12/2022 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 09/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2011 - 09/2010
2	Necrosis 09/2010 - 11/2002
2	Adenocarcinoma of Lung 05/2009 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2009 - 05/2007
1	Acute Radiation Syndrome 10/2019
1	Adenocarcinoma 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Dehydration (Water Stress) 11/2015
1	Asthma (Bronchial Asthma) 01/2013
1	Metaplasia 01/2013
1	Respiratory Hypersensitivity 01/2013
1	Airway Remodeling 01/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Thrombosis (Thrombus) 09/2011
1	Myalgia 07/2011
1	Pulmonary Hypertension 07/2011
1	Rhabdomyolysis 07/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2011
1	Breast Neoplasms (Breast Cancer) 09/2010
1	Myocardial Infarction 09/2010
1	Leukemia 09/2007
1	Aspergillosis 02/2006
1	Carcinoma (Carcinomatosis) 03/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2011
3	Acetates (Acetic Acid Esters)FDA Link 12/2022 - 01/2014
3	CalreticulinIBA 12/2022 - 03/2011
3	CoumarinsIBA 01/2016 - 03/2003
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2011 - 03/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011 - 11/2002
3	Cell Adhesion MoleculesIBA 09/2010 - 03/2004
2	coumarinIBA 01/2014 - 05/2009
2	7,8-dihydroxy-4-methylcoumarinIBA 09/2010 - 05/2007
1	ElementsIBA 10/2019
1	AldehydesIBA 11/2015
1	Alkenes (Olefins)IBA 11/2015
1	Histones (Histone)IBA 01/2014
1	CinnamatesIBA 01/2013
1	CytokinesIBA 01/2013
1	OvalbuminIBA 01/2013
1	AcidsIBA 01/2013
1	8-epi-prostaglandin F2alphaIBA 01/2013
1	ferric chlorideIBA 09/2011
1	oxidized low density lipoproteinIBA 07/2011
1	ethyl 4- (4'- heptanoyloxyphenyl)- 6- methyl- 3,4- dihydropyrimidin- 2- one- 5- carboxylateIBA 07/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 07/2011
1	Coenzyme A (CoA)IBA 07/2011
1	Oxidoreductases (Dehydrogenase)IBA 07/2011
1	Protein Kinase CIBA 07/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2011
1	Protein Isoforms (Isoforms)IBA 07/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2011
1	IonsIBA 09/2010
1	Complex MixturesIBA 09/2010
1	Deferoxamine (Desferal)FDA LinkGeneric 09/2010
1	Chelating AgentsIBA 09/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2010
1	src-Family KinasesIBA 09/2010
1	IronIBA 09/2010
1	7,8-diacetoxy-4-methylthiocoumarinIBA 05/2009
1	7,8-diacetoxy-4-methylcoumarinIBA 05/2009
1	Phosphotransferases (Kinase)IBA 05/2009
1	AntioxidantsIBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009
1	Melphalan (Alkeran)FDA LinkGeneric 09/2007
1	DihydropyridinesIBA 02/2006
1	E-SelectinIBA 03/2004
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2004
1	LactonesIBA 03/2003
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 03/2003
1	PyrazolesIBA 03/2003
1	ChromansIBA 03/2003
1	IsoxazolesIBA 03/2003
1	KetonesIBA 03/2003
1	ChalconesIBA 03/2003
1	NADP (NADPH)IBA 11/2002
1	1-hydroxyxanthoneIBA 11/2002
1	XanthonesIBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2014 - 03/2011
1	Drug Therapy (Chemotherapy) 03/2011